BPG is committed to discovery and dissemination of knowledge
Articles in Press
12/28/2023 5:10:21 AM | Browse: 3916 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 89525
Country Italy
Category Gastroenterology & Hepatology
Manuscript Type Evidence Review
Article Title May ChatGPT be a tool producing medical information for common inflammatory bowel disease patients’ questions? An evidence-controlled analysis
Manuscript Source Invited Manuscript
All Author List Antonietta Gerarda Gravina, Raffaele Pellegrino, Marina Cipullo, Giovanna Palladino, Giuseppe Imperio, Andrea Ventura, Salvatore Auletta, Paola Ciamarra and Alessandro Federico
Funding Agency and Grant Number
Corresponding Author Raffaele Pellegrino, MD, N/A, N/A, Division of Hepatogastroenterology, Department of Precision Medicine, University of Campania Luigi Vanvitelli, Via L. de Crecchio, Naples 80138, Italy. raffaele.pellegrino@unicampania.it
Key Words Crohn’s disease; Ulcerative colitis; Inflammatory bowel disease; Chat Generative Pre-trained Transformer; Large language model; Artificial intelligence
Core Tip Patients with inflammatory bowel disease (IBD) increasingly access information resources online to receive information about disease management. Emerging artificial intelligence (AI) systems such as Chat Generative Pre-trained Transformer (ChatGPT) are taking hold in the daily reality of many patients with IBD. Through them, patients can potentially understand these systems as reliable or substitutes for medical consultation, especially for issues about reluctantly talking to their gastroenterologist. This review, examining ChatGPT’s outputs to common questions from patients with IBD, outlined how, while this AI system can provide some medical information, there are some limitations related to poor updating and the risk of inaccuracies that push for its cautious use.
Citation Gravina AG, Pellegrino R, Cipullo M, Palladino G, Imperio G, Ventura A, Auletta S, Ciamarra P, Federico A. May ChatGPT be a tool producing medical information for common inflammatory bowel disease patients’ questions? An evidence-controlled analysis. World J Gastroenterol 2024; 30(1): 17-33
Received
2023-11-04 07:10
Peer-Review Started
2023-11-04 07:12
To Make the First Decision
Return for Revision
2023-11-30 05:32
Revised
2023-12-07 16:09
Second Decision
2023-12-28 02:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2023-12-28 05:10
Articles in Press
2023-12-28 05:10
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2024-01-03 22:30
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com